Blockchain Registration Transaction Record

HeartBeam's Portable ECG Device Hits 93.4% Accuracy in Pivotal Study

HeartBeam's portable ECG device achieves 93.4% diagnostic accuracy, paving the way for FDA clearance and revolutionizing cardiac care outside hospitals.

This news is a milestone in cardiac care, offering a glimpse into a future where accurate heart monitoring is accessible anywhere, anytime. HeartBeam's technology could significantly reduce the need for hospital visits for ECG monitoring, making cardiac care more convenient and potentially life-saving for millions. Its FDA clearance could herald a new era in portable medical devices, empowering patients with real-time health insights and easing the burden on healthcare systems.